Aceto Corporation Company Profile (NASDAQ:ACET)

About Aceto Corporation (NASDAQ:ACET)

Aceto Corporation logoAceto Corporation (Aceto) is engaged in the marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products. The Company's business is organized along product lines into three segments: Human Health, Pharmaceutical Ingredients and Performance Chemicals. As of June 30, 2016, it distributed over 1,100 chemical compounds used primarily as finished products or raw materials in the agricultural, coatings and industrial chemical industries. The Human Health segment includes finished dosage form generic drugs and nutraceutical products. As of June 30, 2016, the Pharmaceutical Ingredients segment had two product groups: Active Pharmaceutical Ingredients and Pharmaceutical Intermediates. The Performance Chemicals segment includes specialty chemicals and agricultural protection products.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Pharmaceuticals - NEC
  • Sub-Industry: Trading Companies & Distributors
  • Symbol: NASDAQ:ACET
  • CUSIP: 00444610
  • Web:
  • Market Cap: $479.19 million
  • Outstanding Shares: 30,100,000
Average Prices:
  • 50 Day Moving Avg: $15.75
  • 200 Day Moving Avg: $15.31
  • 52 Week Range: $13.50 - $25.98
  • Trailing P/E Ratio: 30.40
  • Foreward P/E Ratio: 8.99
  • P/E Growth: 1.16
Sales & Book Value:
  • Annual Revenue: $579.12 million
  • Price / Sales: 0.83
  • Book Value: $13.36 per share
  • Price / Book: 1.19
  • Annual Dividend: $0.26
  • Dividend Yield: 1.6%
  • EBIDTA: $63.31 million
  • Net Margins: 2.79%
  • Return on Equity: 11.15%
  • Return on Assets: 4.94%
  • Debt-to-Equity Ratio: 0.88%
  • Current Ratio: 2.07%
  • Quick Ratio: 1.47%
  • Average Volume: 158,502 shs.
  • Beta: 1.27
  • Short Ratio: 18.72

Frequently Asked Questions for Aceto Corporation (NASDAQ:ACET)

What is Aceto Corporation's stock symbol?

Aceto Corporation trades on the NASDAQ under the ticker symbol "ACET."

How often does Aceto Corporation pay dividends? What is the dividend yield for Aceto Corporation?

Aceto Corporation announced a quarterly dividend on Thursday, May 4th. Investors of record on Friday, June 9th will be paid a dividend of $0.065 per share on Friday, June 23rd. This represents a $0.26 annualized dividend and a yield of 1.63%. The ex-dividend date is Wednesday, June 7th. View Aceto Corporation's Dividend History.

How were Aceto Corporation's earnings last quarter?

Aceto Corporation (NASDAQ:ACET) announced its earnings results on Thursday, May, 4th. The company reported $0.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.44 by $0.05. The firm had revenue of $190.10 million for the quarter, compared to analysts' expectations of $195.09 million. Aceto Corporation had a return on equity of 11.15% and a net margin of 2.79%. The firm's revenue was up 20.4% on a year-over-year basis. During the same period in the previous year, the firm earned $0.42 EPS. View Aceto Corporation's Earnings History.

When will Aceto Corporation make its next earnings announcement?

Aceto Corporation is scheduled to release their next quarterly earnings announcement on Thursday, August, 24th 2017. View Earnings Estimates for Aceto Corporation.

Where is Aceto Corporation's stock going? Where will Aceto Corporation's stock price be in 2017?

3 brokers have issued 12-month price targets for Aceto Corporation's shares. Their predictions range from $19.00 to $21.00. On average, they expect Aceto Corporation's share price to reach $20.00 in the next twelve months. View Analyst Ratings for Aceto Corporation.

Who are some of Aceto Corporation's key competitors?

Who are Aceto Corporation's key executives?

Aceto Corporation's management team includes the folowing people:

  • Albert L. Eilender, Chairman of the Board
  • Salvatore J Guccione Sr, President, Chief Executive Officer, Director
  • Douglas A Roth, Chief Financial Officer, Senior Vice President
  • Walter J. Kaczmarek III, Chief Operating Officer
  • Steven Rogers, Senior Vice President, General Counsel, Corporate Secretary
  • Charles J. Alaimo, Senior Vice President - Human Resources
  • Raymond Bartone, Senior Vice President - Nutritionals
  • Frank V. DeBenedittis, Senior Vice President - Corporate Business Development
  • Terry Kippley, Senior Vice President - Agricultural Protection Products
  • Carlos Restrepo, Senior Vice President - Performance Chemicals

Who owns Aceto Corporation stock?

Aceto Corporation's stock is owned by many different of institutional and retail investors. Top institutional investors include Dimensional Fund Advisors LP (8.41%), Northern Trust Corp (5.17%), Vanguard Group Inc. (5.14%), Deprince Race & Zollo Inc. (4.28%), Denver Investment Advisors LLC (2.95%) and State Street Corp (2.70%). Company insiders that own Aceto Corporation stock include Albert L Eilender, Charles John Alaimo, Daniel B Yarosh, Douglas A Roth, Frank Debenedittis, Hans C Noetzli, Nicolas I Shackley, Raymond Bartone, Salvatore J Sr Guccione Sr, Salvatore J Sr Guccione, Sr, Satish Srinivasan, Steven Rogers, Terry Kippley, Walter J Kaczmarek III and William N Britton. View Institutional Ownership Trends for Aceto Corporation.

Who sold Aceto Corporation stock? Who is selling Aceto Corporation stock?

Aceto Corporation's stock was sold by a variety of institutional investors in the last quarter, including Citadel Advisors LLC, AlphaOne Investment Services LLC, Thrivent Financial For Lutherans, Goldman Sachs Group Inc., Systematic Financial Management LP, Bank of Montreal Can, Petrus Trust Company LTA and Public Sector Pension investment Board. Company insiders that have sold Aceto Corporation stock in the last year include Albert L Eilender, Charles John Alaimo, Daniel B Yarosh, Douglas A Roth, Frank Debenedittis, Hans C Noetzli, Nicolas I Shackley, Raymond Bartone, Salvatore J Sr Guccione Sr, Satish Srinivasan, Steven Rogers and Walter J Kaczmarek III. View Insider Buying and Selling for Aceto Corporation.

Who bought Aceto Corporation stock? Who is buying Aceto Corporation stock?

Aceto Corporation's stock was purchased by a variety of institutional investors in the last quarter, including Northern Trust Corp, Vanguard Group Inc., Ameriprise Financial Inc., King Luther Capital Management Corp, Dimensional Fund Advisors LP, Municipal Employees Retirement System of Michigan, KBC Group NV and Bridge City Capital LLC. View Insider Buying and Selling for Aceto Corporation.

How do I buy Aceto Corporation stock?

Shares of Aceto Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Aceto Corporation's stock price today?

One share of Aceto Corporation stock can currently be purchased for approximately $15.92.

MarketBeat Community Rating for Aceto Corporation (NASDAQ ACET)
Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  48 (Vote Outperform)
Underperform Votes:  83 (Vote Underperform)
Total Votes:  131
MarketBeat's community ratings are surveys of what our community members think about Aceto Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Aceto Corporation (NASDAQ:ACET) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $20.00 (25.63% upside)

Analysts' Ratings History for Aceto Corporation (NASDAQ:ACET)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/31/2017Canaccord GenuityInitiated CoverageBuy -> Buy$19.00HighView Rating Details
2/3/2017Craig HallumDowngradeBuy -> HoldN/AView Rating Details
1/31/2017First AnalysisDowngradeOverweight -> Equal WeightN/AView Rating Details
(Data available from 8/21/2015 forward)


Earnings History for Aceto Corporation (NASDAQ:ACET)
Earnings by Quarter for Aceto Corporation (NASDAQ:ACET)
Earnings History by Quarter for Aceto Corporation (NASDAQ ACET)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/24/2017$0.44N/AView Earnings Details
5/4/2017Q3 2017$0.44$0.39$195.09 million$190.10 millionViewListenView Earnings Details
2/2/2017Q2 2017$0.32$0.24$136.65 million$125.60 millionViewListenView Earnings Details
11/2/2016Q1 17$0.29$0.28$132.88 million$128.02 millionViewListenView Earnings Details
8/25/2016Q416$0.39$0.35$146.71 million$135.40 millionViewListenView Earnings Details
5/5/2016Q3$0.39$0.42$150.07 million$157.90 millionViewListenView Earnings Details
2/4/2016Q2$0.30$0.36$132.71 million$131.70 millionViewListenView Earnings Details
11/5/2015Q116$0.34$0.37$139.89 million$133.50 millionViewListenView Earnings Details
9/10/2015Q415$0.31$0.48$146.68 million$146.60 millionViewListenView Earnings Details
5/7/2015Q3$0.29$0.34$140.00 million$145.80 millionViewListenView Earnings Details
2/5/2015Q115$0.26$0.28$130.00 million$13.00 millionViewListenView Earnings Details
11/6/2014Q414$0.29$0.23$146.40 million$130.80 millionViewListenView Earnings Details
9/4/2014Q314$0.17$0.21$134.23 million$139.60 millionViewListenView Earnings Details
5/8/2014Q214$0.28$0.19$136.70 million$124.83 millionViewListenView Earnings Details
2/7/2014Q114$0.24$0.24$147.02 million$116.50 millionViewListenView Earnings Details
8/28/2013Q4 2013$0.20$0.19$113.10 million$123.10 millionViewListenView Earnings Details
5/9/2013Q3 2013$0.26$0.34$128.56 million$150.90 millionViewListenView Earnings Details
11/8/2012Q113$0.19$0.18$110.85 million$111.70 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Aceto Corporation (NASDAQ:ACET)
2017 EPS Consensus Estimate: $1.53
2018 EPS Consensus Estimate: $1.89
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$0.29$0.29$0.29
Q2 20172$0.27$0.42$0.35
Q3 20172$0.39$0.47$0.43
Q4 20172$0.43$0.50$0.47
Q1 20182$0.42$0.46$0.44
Q2 20182$0.39$0.50$0.45
Q3 20182$0.50$0.51$0.51
Q4 20181$0.50$0.50$0.50
(Data provided by Zacks Investment Research)


Current Dividend Information for Aceto Corporation (NASDAQ:ACET)
Most Recent Dividend:6/23/2017
Annual Dividend:$0.26
Dividend Yield:1.63%
Payout Ratio:50.00% (Trailing 12 Months of Earnings)
19.12% (Based on This Year's Estimates)
14.69% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Aceto Corporation (NASDAQ:ACET)

Dividend History by Quarter for Aceto Corporation (NASDAQ ACET)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Aceto Corporation (NASDAQ:ACET)
Insider Ownership Percentage: 4.10%
Institutional Ownership Percentage: 81.06%
Insider Trades by Quarter for Aceto Corporation (NASDAQ:ACET)
Institutional Ownership by Quarter for Aceto Corporation (NASDAQ:ACET)
Insider Trades by Quarter for Aceto Corporation (NASDAQ:ACET)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/2/2017Walter J Kaczmarek IIICOOSell7,083$16.57$117,365.31View SEC Filing  
7/6/2017Albert L EilenderChairmanSell6,500$15.21$98,865.00View SEC Filing  
7/6/2017Frank DebenedittisInsiderSell2,089$15.28$31,919.92View SEC Filing  
7/6/2017Salvatore J Sr Guccione SrCEOSell7,421$15.21$112,873.41View SEC Filing  
7/5/2017Charles John AlaimoInsiderSell2,612$15.48$40,433.76View SEC Filing  
7/5/2017Douglas A RothCFOSell5,075$15.47$78,510.25View SEC Filing  
7/5/2017Steven RogersSVPSell2,285$15.45$35,303.25View SEC Filing  
3/9/2017Frank DebenedittisInsiderSell3,600$14.94$53,784.00View SEC Filing  
1/17/2017Daniel B YaroshDirectorSell891$20.69$18,434.79View SEC Filing  
12/9/2016Raymond BartoneInsiderSell5,000$21.54$107,700.00View SEC Filing  
12/8/2016Nicolas I ShackleyInsiderSell2,500$21.27$53,175.00View SEC Filing  
11/30/2016Frank DebenedittisInsiderSell7,040$20.22$142,348.80View SEC Filing  
11/29/2016Satish SrinivasanCOOSell12,917$20.02$258,598.34View SEC Filing  
11/28/2016Albert L EilenderChairmanSell18,500$19.88$367,780.00View SEC Filing  
11/23/2016Steven RogersSVPSell2,400$19.53$46,872.00View SEC Filing  
11/14/2016Hans C NoetzliDirectorSell6,000$18.32$109,920.00View SEC Filing  
9/8/2016Salvatore J Sr Guccione SrInsiderSell260$19.64$5,106.40View SEC Filing  
9/7/2016Charles John AlaimoInsiderSell25$19.43$485.75View SEC Filing  
9/6/2016Albert L EilenderChairmanSell12,936$19.92$257,685.12View SEC Filing  
9/6/2016Frank DebenedittisInsiderSell4,580$19.85$90,913.00View SEC Filing  
9/6/2016Satish SrinivasanCOOSell3,980$19.84$78,963.20View SEC Filing  
9/6/2016Steven RogersSVPSell2,167$20.04$43,426.68View SEC Filing  
9/2/2016Charles John AlaimoInsiderSell2,567$19.85$50,954.95View SEC Filing  
7/19/2016Satish SrinivasanCOOSell595$25.48$15,160.60View SEC Filing  
7/7/2016Frank DebenedittisVPSell3,275$23.34$76,438.50View SEC Filing  
7/6/2016Albert L EilenderChairmanSell7,690$22.53$173,255.70View SEC Filing  
7/6/2016Charles John AlaimoSVPSell3,639$22.41$81,549.99View SEC Filing  
7/6/2016Douglas A RothCFOSell6,770$22.72$153,814.40View SEC Filing  
7/6/2016Salvatore J Sr Guccione SrCEOSell10,945$23.25$254,471.25View SEC Filing  
7/6/2016Satish SrinivasanCOOSell3,250$22.80$74,100.00View SEC Filing  
7/6/2016Steven RogersVPSell3,275$22.50$73,687.50View SEC Filing  
6/7/2016Terry KippleyVPSell2,000$22.50$45,000.00View SEC Filing  
6/7/2016William N BrittonDirectorSell4,200$23.12$97,104.00View SEC Filing  
6/6/2016Frank DebenedittisVPSell6,810$22.63$154,110.30View SEC Filing  
6/6/2016Satish SrinivasanCOOSell3,497$22.69$79,346.93View SEC Filing  
5/31/2016Albert L EilenderChairmanSell9,881$22.21$219,457.01View SEC Filing  
5/26/2016Douglas A RothCFOSell7,000$22.16$155,120.00View SEC Filing  
3/10/2016Raymond BartoneSVPSell3,000$22.40$67,200.00View SEC Filing  
3/8/2016Hans C NoetzliDirectorSell6,500$22.91$148,915.00View SEC Filing  
3/2/2016Frank DebenedittisVPSell3,000$21.98$65,940.00View SEC Filing  
3/1/2016Steven RogersVPSell2,100$21.82$45,822.00View SEC Filing  
2/25/2016Albert L EilenderChairmanSell9,281$21.79$202,232.99View SEC Filing  
2/23/2016Charles John AlaimoSVPSell4,750$21.91$104,072.50View SEC Filing  
2/23/2016Douglas A RothCFOSell17,000$21.52$365,840.00View SEC Filing  
12/9/2015Satish SrinivasanCOOSell3,000$27.02$81,060.00View SEC Filing  
12/9/2015Terry KippleyVPSell1,550$27.06$41,943.00View SEC Filing  
12/8/2015Nicolas I ShackleySVPSell3,000$26.70$80,100.00View SEC Filing  
12/1/2015Charles John AlaimoSVPSell3,000$28.22$84,660.00View SEC Filing  
11/25/2015Hans C. NoetzliDirectorSell3,000$27.52$82,560.00View SEC Filing  
11/24/2015Steven RogersVPSell3,000$27.56$82,680.00View SEC Filing  
10/15/2015Albert L. EilenderChairmanSell8,155$28.90$235,679.50View SEC Filing  
9/10/2015Charles John AlaimoSVPSell1,620$22.14$35,866.80View SEC Filing  
9/10/2015Douglas A. RothCFOSell6,250$22.14$138,375.00View SEC Filing  
9/10/2015Frank DebenedittisVPSell2,553$22.14$56,523.42View SEC Filing  
9/10/2015Salvatore J. Sr Guccione, Sr.CEOSell9,386$22.14$207,806.04View SEC Filing  
7/2/2015Albert L EilenderChairmanSell10,938$24.20$264,699.60View SEC Filing  
7/2/2015Charles John AlaimoSVPSell2,998$24.19$72,521.62View SEC Filing  
7/2/2015Douglas A RothCFOSell5,748$24.19$139,044.12View SEC Filing  
7/2/2015Frank DebenedittisVPSell2,629$24.19$63,595.51View SEC Filing  
7/2/2015Salvatore J Sr Guccione SrCEOSell9,114$24.19$220,467.66View SEC Filing  
7/2/2015Satish SrinivasanCOOSell1,921$24.19$46,468.99View SEC Filing  
6/8/2015Raymond BartoneSVPSell5,000$24.44$122,200.00View SEC Filing  
6/3/2015Frank DebenedittisVPSell4,000$24.41$97,640.00View SEC Filing  
5/27/2015Charles John AlaimoSVPSell2,000$23.19$46,380.00View SEC Filing  
5/12/2015William N BrittonDirectorSell13,000$21.31$277,030.00View SEC Filing  
3/4/2015Douglas A RothCFOSell5,000$20.99$104,950.00View SEC Filing  
3/4/2015Natasha GiordanoDirectorSell2,164$20.92$45,270.88View SEC Filing  
2/12/2015Douglas A RothCFOSell6,000$19.91$119,460.00View SEC Filing  
2/10/2015Charles John AlaimoSVPSell2,000$20.15$40,300.00View SEC Filing  
12/9/2014Frank DebenedittisVPSell3,000$21.25$63,750.00View SEC Filing  
12/5/2014Douglas A RothCFOSell7,000$22.07$154,490.00View SEC Filing  
12/3/2014Terry KippleyVPSell1,950$21.35$41,632.50View SEC Filing  
12/2/2014Terry KippleyVPSell1,797$21.45$38,545.65View SEC Filing  
12/1/2014Satish SrinivasanCOOSell1,430$21.00$30,030.00View SEC Filing  
11/11/2014Charles John AlaimoSVPSell2,250$21.22$47,745.00View SEC Filing  
9/9/2014Douglas A RothCFOSell6,000$21.57$129,420.00View SEC Filing  
9/9/2014Natasha GiordanoDirectorSell1,453$21.94$31,878.82View SEC Filing  
9/9/2014Raymond BartoneSVPSell3,000$21.49$64,470.00View SEC Filing  
9/9/2014Steven RogersVPSell8,335$21.50$179,202.50View SEC Filing  
9/2/2014Albert L EilenderChairmanSell7,144$19.14$136,736.16View SEC Filing  
8/29/2014Hans C NoetzliDirectorSell2,000$18.85$37,700.00View SEC Filing  
8/15/2014Hans C NoetzliDirectorSell2,000$18.63$37,260.00View SEC Filing  
8/4/2014Albert L EilenderChairmanSell4,195$16.71$70,098.45View SEC Filing  
8/1/2014Hans C NoetzliDirectorSell2,000$16.67$33,340.00View SEC Filing  
7/25/2014Albert L EilenderChairmanSell2,450$17.63$43,193.50View SEC Filing  
7/3/2014Hans C NoetzliDirectorSell2,000$17.86$35,720.00View SEC Filing  
7/2/2014Albert L EilenderChairmanSell1,750$18.05$31,587.50View SEC Filing  
6/6/2014Charles John AlaimoSVPSell2,000$17.51$35,020.00View SEC Filing  
6/6/2014Natasha GiordanoDirectorSell1,160$17.28$20,044.80View SEC Filing  
6/6/2014Steven RogersVPSell2,333$17.58$41,014.14View SEC Filing  
6/4/2014Frank DebenedittisVPSell30,000$17.09$512,700.00View SEC Filing  
6/4/2014Nicolas I ShackleyInsiderSell1,000$17.29$17,290.00View SEC Filing  
6/2/2014Douglas A RothCFOSell6,500$17.10$111,150.00View SEC Filing  
6/2/2014Natasha GiordanoDirectorSell1,149$17.43$20,027.07View SEC Filing  
5/23/2014Natasha GiordanoDirectorSell1,128$17.91$20,202.48View SEC Filing  
5/21/2014Natasha GiordanoDirectorSell1,110$17.81$19,769.10View SEC Filing  
3/10/2014Terry KippleyVPSell3,817$19.17$73,171.89View SEC Filing  
2/14/2014Roger Weaving, Jr.SVPSell6,000$18.96$113,760.00View SEC Filing  
11/12/2013Roger Weaving, Jr.SVPSell14,605$19.03$277,933.15View SEC Filing  
9/6/2013Raymond BartoneSVPSell19,000$14.84$281,960.00View SEC Filing  
6/7/2013Roger Weaving JrVPSell4,420$13.02$57,548.40View SEC Filing  
6/6/2013Guillaume Saint-ClairVPSell15,332$13.01$199,469.32View SEC Filing  
6/4/2013Douglas A RothCFOSell30,000$13.31$399,300.00View SEC Filing  
6/4/2013Eis Jan VanDirectorSell9,000$13.39$120,510.00View SEC Filing  
5/24/2013Ronald GoldCOOSell25,000$11.71$292,750.00View SEC Filing  
5/22/2013Frank DebenedittisVPSell8,300$11.86$98,438.00View SEC Filing  
5/21/2013Frank DebenedittisVPSell7,867$12.00$94,404.00View SEC Filing  
5/17/2013Douglas A RothCFOSell20,200$11.31$228,462.00View SEC Filing  
5/17/2013Guillaume Saint-ClairVPSell2,250$11.15$25,087.50View SEC Filing  
5/15/2013Ronald GoldCOOSell55,000$11.23$617,650.00View SEC Filing  
5/14/2013David B RosenVPSell40,000$11.05$442,000.00View SEC Filing  
5/14/2013Roger Weaving JrSVPSell5,600$11.09$62,104.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Aceto Corporation (NASDAQ:ACET)
Latest Headlines for Aceto Corporation (NASDAQ:ACET)
DateHeadline logoAceto Corporation (ACET) to Release Quarterly Earnings on Thursday - August 17 at 1:16 AM logoACETO Corporation Schedules Fourth Quarter & Fiscal 2017 Financial Results News Release and Conference Call - August 11 at 3:39 PM logoAceto Corporation (NASDAQ:ACET) Receives Average Recommendation of "Hold" from Analysts - August 6 at 7:10 AM logoInsider Selling: Aceto Corporation (NASDAQ:ACET) COO Sells 7,083 Shares of Stock - August 3 at 9:04 PM logoACETO Subsidiary, Rising Pharmaceuticals, Announces Product Launches - July 21 at 4:40 PM logoAceto Corporation (ACET) Given Average Rating of "Hold" by Analysts - July 12 at 10:10 PM logoZacks Investment Research Upgrades Aceto Corporation (NASDAQ:ACET) to Hold - July 11 at 6:02 PM logoInsider Selling: Aceto Corporation (ACET) CFO Sells 5,075 Shares of Stock - July 7 at 8:41 PM logoAceto Corporation (NASDAQ:ACET) CEO Salvatore J. Sr Guccione, Sr. Sells 7,421 Shares - July 7 at 8:40 PM logoAceto Corporation (ACET) Chairman Sells $98,865.00 in Stock - July 7 at 4:58 PM logoCharles John Alaimo Sells 2,612 Shares of Aceto Corporation (ACET) Stock - July 7 at 4:58 PM logoAceto Corporation (NASDAQ:ACET) SVP Steven Rogers Sells 2,285 Shares - July 7 at 4:58 PM logoFrank Debenedittis Sells 2,089 Shares of Aceto Corporation (NASDAQ:ACET) Stock - July 7 at 4:58 PM logoForm 4 ACETO CORP For: Jul 06 Filed by: GUCCIONE SALVATORE J SR - July 7 at 4:20 PM logoACETO to Present at the Singular Summer Solstice Conference - July 7 at 4:20 PM logoStrategy To YieldBoost Aceto Corp From 1.7% To 10.9% Using Options - July 3 at 3:26 PM logoAceto Corporation (ACET) versus Valhi (VHI) Head to Head Contrast - June 20 at 4:14 PM logoACETO Subsidiary, Rising Pharmaceuticals, Launches Chlorthalidone Tablets, 25 mg and 50 mg, and Glipizide Extended Release Tablets, 2.5 mg, 5 mg and 10 mg - June 20 at 3:40 PM logoETFs with exposure to Aceto Corp. : June 15, 2017 - June 15 at 3:26 PM logoAceto Corp. breached its 50 day moving average in a Bullish Manner : ACET-US : June 12, 2017 - June 12 at 3:33 PM logoAceto Corp. : ACET-US: Dividend Analysis : June 09th, 2017 (record date) : By the numbers : June 8, 2017 - June 8 at 3:21 PM logoBrokerages Expect Aceto Co. (ACET) to Announce $0.47 EPS - June 8 at 8:52 AM logoETFs with exposure to Aceto Corp. : June 2, 2017 - June 2 at 3:40 PM logoACETO Subsidiary, Rising Pharmaceuticals, Launches Atomoxetine Capsules, 10, 18, 25, 40, 60, 80 & 100 mg - May 31 at 11:19 AM logoETFs with exposure to Aceto Corp. : May 23, 2017 - May 23 at 3:18 PM logoAceto Corp. :ACET-US: Earnings Analysis: Q3, 2017 By the Numbers : May 22, 2017 - May 22 at 3:18 PM logoQ4 2017 EPS Estimates for Aceto Co. Decreased by First Analysis (ACET) - May 15 at 9:04 AM logoFirst Analysis Research Analysts Lower Earnings Estimates for Aceto Co. (ACET) - May 12 at 1:20 PM logoFY2017 EPS Estimates for Aceto Co. (ACET) Cut by Craig Hallum - May 10 at 10:00 AM logoEdited Transcript of ACET earnings conference call or presentation 5-May-17 1:00pm GMT - May 9 at 3:17 PM logoAceto Corp. breached its 50 day moving average in a Bearish Manner : ACET-US : May 8, 2017 - May 8 at 11:28 AM logoInvestor Network: Aceto Corporation to Host Earnings Call - May 5 at 3:18 PM logoAceto Co. (ACET) Announces Quarterly Earnings Results, Misses Expectations By $0.05 EPS - May 4 at 11:24 PM logoACETO Reports Fiscal 2017 Third Quarter Results - May 4 at 8:19 PM logoAceto posts 3Q profit - May 4 at 7:57 PM logoZacks Investment Research Lowers Aceto Co. (ACET) to Sell - May 4 at 7:06 PM logoAceto Co. (ACET) Plans Quarterly Dividend of $0.07 - May 4 at 5:46 PM logoFavorable News Coverage Very Likely to Impact Aceto (ACET) Share Price - May 4 at 3:48 PM logoACETO Board of Directors Declares Quarterly Cash Dividend - May 4 at 3:17 PM logoAceto Co. (ACET) Set to Announce Earnings on Thursday - May 2 at 7:24 AM logoAceto (ACET) Receiving Favorable Press Coverage, Analysis Finds - April 29 at 8:44 AM logoAceto (ACET) Given Daily Media Impact Rating of 0.36 - April 26 at 9:19 AM logoAceto Corp. – Value Analysis (NASDAQ:ACET) : April 24, 2017 - April 24 at 3:20 PM logoACETO Corporation Schedules Third Quarter Fiscal 2017 Financial Results News Release and Conference Call - April 21 at 3:15 PM logoAceto Corp. breached its 50 day moving average in a Bullish Manner : ACET-US : April 21, 2017 - April 21 at 3:15 PM logoAceto (ACET) Given Media Sentiment Score of -0.36 - April 21 at 7:46 AM logoVery Positive Press Coverage Very Likely to Effect Aceto (ACET) Stock Price - April 14 at 10:46 AM logoDemocrats found a way to speak Trump's language in pharma debate - April 7 at 5:35 AM logoAceto Co. (ACET) Short Interest Down 9.2% in March - April 4 at 3:00 PM logoACETO Subsidiary, Rising Pharmaceuticals, Launches Zileuton Extended Release Tablets, 600 mg - March 31 at 3:24 PM



Aceto Corporation (ACET) Chart for Monday, August, 21, 2017

This page was last updated on 8/21/2017 by Staff